SUMMARY Sera from 180 patients with suspected toxoplasmic lymphadenopathy were examined for antitoxoplasma IgM by an enzyme-linked immunosorbent assay (ELISA), using antibody class capture (ACCA). Of 82 positive ACCA results, 78 were confirmed by testing the IgM fractions of the sera, obtained by sucrose density gradient centrifugation (SDGC). The four positive results which could not be confirmed were all from patients with at least a year's history of lymphadenopathy. Sera from 10 patients with low Sabin Feldman dye test (DT) titres gave positive ACCA results and subsequent specimens from them showed a rise in antibody concentration, confirming the diagnosis of acute toxoplasmosis.
The diagnostic value of detecting specific immunc globulin M (IgM) in acute and congenital toxoplasmosis is well established.' The antitoxoplasma IgM immunofluorescent antibody test (IgM-IFA) is widely used for this purpose but has been shown to have serious disadvantages. False-positive results often occur when either rheumatoid factor (RF) or antinuclear factor (ANF) are present in the patient's serum.23 False-negative results may occur when high concentrations of antitoxoplasma IgG are present because they compete for antigenic sites and inhibit the demonstration of antitoxoplasma IgM.4 Other methods employ the physical separation of IgM from IgG by either sucrose density gradient centrifugation (SDGC) or exclusion chromatography5
followed by serological tests in the presence and absence of 2-mercaptoethanol (2-ME) as has been described for the detection of antirubella 1gM.6
These fractionation techniques are time-consuming, require expensive apparatus and are not practicable for large numbers of specimens.
An enzyme-linked immunosorbent assay
Accepted for publication 5 January 1982 (ELISA) using antibody class capture assay for the detection of antitoxoplasma IgM (ACCA) is an alternative to the above methods. IgM can be separated from other immunoglobulins by selective binding to antihuman , chain immunoglobulin coated onto plastic material. The antitoxoplasma activity of captured IgM can then be assayed by adding toxoplasma antigen followed by enzyme-labelled antibody as described for hepatitis A antigen.7 The development and use of an ACCA in cases of toxoplasma lymphadenopathy is described. Its possible use in testing large numbers of specimens is discussed.
Material and methods

SPECIMENS
Serum samples were obtained from 180 patients who had lymphadenopathy, with dye test8 (DT) titres ranging from <1/4 to 1/4096 or greater (<2-2000 IU/ml), 20 patients whose sera contained RF, three patients whose sera contained ANF, 50 patients with positive DT titres but without lymphadenopathy, and 100 patients with negative DTs. The optimal dilution of reagents was determined by chessboard titrations using a weakly positive antitoxoplasma IgM serum at a dilution of 1/40. The highest T:N ratios were found when the antihuman IgM was used at 1/1000, the toxoplasma antigen at 1/40 and the F(ab')2 conjugate at 1/2000 for two batches and 1/2500 for the third.
Antihuman IgM was diluted in PBS and 200 ,l volumes added to cuvettes which were stored in a sealed, humid box for at least 24 h and then until used. The required number of cuvettes were washed nine times with PBST, and 200 ,ul volumes of PBST containing 1% NRS were added to the empty cuvettes. After three hours they were washed nine times as before, and 200 ,ul volumes of test sera diluted in PBST containing 2% NRS and 1% BSA were added. Four hours later the cuvettes were again washed and 200 ,ul volumes of antigen, diluted in PBST containing 5% NRS and 5% BSA were added.
After overnight incubation the cuvettes were washed and 200 ,ul volumes of F(ab')2 conjugate, diluted in PBST containing 5% NRS and 5% BSA, were added, and incubated for one hour. The cuvettes were again washed and 250 ,ul volumes of freshly prepared enzyme-substrate were added. After incubation in a darkened box for 45 min the absorbances were read at 418 nm after zeroing the PR 50 with the substrate solution as a blank.
DETERMINATION OF TOXOPLASMA ANTIBODY BY SDGC Sucrose solutions were prepared in 0-15 M NaCl at concentrations (wt/vol) of 37*5%, 31%, 25%, 18% and 12.5%. Density gradients were prepared by layering 700 ,/l volumes of the sucrose solutions, in the stated order, into polypropylene tubes (5-5 ml, MSE Scientific Instruments Ltd, Manor Royal, Crawley, Sussex). Serum (200 , ul) was mixed with an equal volume of 0 15 M NaCl and layered on top of the sucrose solutions. The tubes were centrifuged at 80 OOOg for 18 h in a Prepspin 50 centrifuge (MSE Scientific Instruments). Ten fractions of approximately 400 ,ul were collected by piercing the bottom of the tube and collecting drops. The first four fractions collected were tested in the presence and absence of 2-ME. Of each fraction, 150 ,ul was added to two tubes, one tube received 50 Al of 0-15 M NaCl and the other 50 ,l of 0.05 M 2-ME, the tubes were incubated at 37°C for one hour. The contents of both sets of tubes were examined by the DT, IgM-IFA and indirect haemagglutination test (IHA). When disruption of IgM occurred, reducing the titre obtained with the 2-ME fraction by eightfold or more, it was considered that specific antitoxoplasma IgM was present in the serum. (Table 2) . The ACCA and SDGC tests were positive with both specimens from all 10 patients whereas the IgM-IFA on whole serum was positive with seven first specimens and only two second specimens from these patients.
The sensitivity and specificity of the ACCA was compared with the IgM-IFA on whole serum diluted 1/5 and neat IgM fractions of sera after SDGC (Table 3) . Of the sera from 180 patients with lym- phadenopathy only 34 were positive when the whole serum was tested by IgM-IFA, 54 were positive when competitive IgG had been removed by SDGC. The IgM-IFA therefore, proved to be far less sensitive than the ACCA. False-positive results occurred with 10 of 20 sera containing RF and two of three sera containing ANF when tested by IgM-IFA whereas all were negative when tested by ACCA. Sera from 100 patients without lymphadenopathy and with negative DTs and 50 patients without lymphadenopathy and DT titres ranging from 1/16 to 1/256 were also tested. All were negative with ACCA, one gave a positive result with IgM-IFA but this specimen was subsequently shown to contain RF.
Discussion
The use of a F(ab')2 peroxidase conjugate has undoubtedly increased the specificity of ACCA for the detection of antitoxoplasma IgM and has eliminated the problems caused by RF and ANF. Other authors using a similar method, originally found the IgG fraction of antitoxoplasma rabbit serum, conjugated to alkaline phosphatase, did not cause falsepositive results with sera containing RF or ANF.'2
They have since reported false-positive results with this method but have also shown that these could be avoided by using F(ab')2 conjugate.'3 In a recent letter the same authors report that when F(ab')2 conjugate was used, false-positive results could occur with sera from patients who had received rabbit antithymocyte globulin.'4 These patients were heart transplant recipients and had developed IgM antirabbit antibodies. The sensitivity of the ACCA is increased by the addition of NRS and BSA to the diluents. This results in a reduction of the mean absorbance of the negative sera whereas the absorbances of positive sera remain unaffected. Higher T:N ratios and increased sensitivity are therefore attained. Acute cases of toxoplasmic lymphadenopathy can be correctly diagnosed early in the disease by the examination of only a single specimen of serum. This diagnosis cannot be made on the DT result of the first specimen alone and a second specimen is required to establish a rise in titre. An IgM-IFA on whole serum can identify some early cases but it is of lower sensitivity and associated with false-positive and falsenegative results.
Studies of the duration of antitoxoplasma IgM after onset of lymphadenopathy are in progress and will be published in due course. Preliminary findings suggest that the antitoxoplasma IgM response varies considerably in individual patients. In one case it was detectable for only three months, in another it was detectable for one year after onset. In the majority of patients so far studied, when sequential specimens were tested, antitoxoplasma IgM could be detected by both ACCA and SDGC methods for about six months after onset. However, the ACCA method appears to detect antitoxoplasma IgM for a slightly longer period than the SDGC method.
The antigen for the tests was prepared from toxoplasma-infected membranes of hens' eggs. This antigen was used because it was readily available. However, most of the sera were also tested using an antigen prepared from water lysates of toxoplasma derived from mouse peritoneal exudates and similar results were obtained. 
